文献速递儿童青少年精神

自闭症中微生物源代谢物升高:一种独特ASD表型的诊断筛查方法

Elevated microbially-derived metabolites in autism: a possible diagnostic screening test for a distinct ASD phenotype.
PubMed 文献 · Mol Psychiatry · 2026-05-26

多中心研究检测52名2至11岁ASD儿童与47名健康发育儿童尿液中微生物源代谢物浓度,发现ASD组多种代谢物显著升高,部分高出100至1000倍。以任一代谢物升高分类的敏感度为90%、特异度为100%,提示约90% ASD儿童存在可客观量化的ASD-MDM表型。

要点

  • ASD儿童尿中多种微生物源代谢物浓度显著高于健康儿童。
  • 任一代谢物升高的分类敏感度90%、特异度100%。
  • 约90% ASD儿童可归为ASD-MDM独特表型。

核心结论

  • ASD儿童尿液中多种微生物源代谢物显著升高,可作为一种非侵入性诊断筛查指标。
  • 约90%的ASD儿童存在以尿液代谢物客观定量定义的ASD-MDM表型。

研究设计与样本

  • 多中心研究纳入52名2至11岁ASD儿童和47名健康发育儿童。
  • 先以半定量液相色谱-质谱联用(LC-MS)检测,再以靶向定量LC-MS测定尿液微生物源代谢物浓度。

主要发现

  • ASD组多种微生物源代谢物浓度显著高于健康发育组。
  • 升高的代谢物包括苯丙氨酸衍生、色氨酸衍生和酵母衍生代谢物。
  • 几乎所有ASD儿童有一种或多种代谢物浓度超过任何健康儿童,部分高出100至1000倍。
  • ASD儿童平均有3种代谢物水平超过任何健康儿童,健康儿童按定义为零。

关键数值与推荐

  • 以一种或多种代谢物升高进行分类,敏感度为90%,特异度为100%。
  • 该MDM SystemTM筛查方法适用于2至11岁儿童。

临床怎么用

  • 尿液微生物源代谢物检测可作为2至11岁儿童ASD的非侵入性诊断筛查辅助手段。
  • 代谢物客观定量结果有助于识别ASD-MDM表型,为后续分层干预提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many studies have confirmed that a subset of children with autism spectrum disorder (ASD) have unusually high urinary concentrations of microbially-derived metabolites (MDMs) such as p-cresol sulfate and indoxyl sulfate. We hypothesized that these MDMs may affect neurodevelopment through the gut-brain axis and that a sub-phenotype characterized by gut dysbiosis may be present in most ASD individuals. This multi-site study involved measuring the concentrations of many MDMs in the urine of 52 children with ASD and 47 healthy, typically developing (TD) children, aged 2 to 11 years. The measurements were conducted first with semiquantitative Liquid Chromatography and Mass Spectrometry (LC-MS), followed by targeted quantitative LC-MS. The ASD group had significantly higher concentrations of many MDMs compared to the TD group. The MDMs included phenylalanine-derived, tryptophan-derived, and yeast-derived MDMs. Almost all children with ASD had one or more MDMs at concentrations above any TD child, and sometimes 100-1000× higher. The children with ASD had an average of 3 MDMs at levels above any TD child, compared to zero (by definition) for the TD children. Classification using one or more elevated MDM yielded a sensitivity of 90% and a specificity of 100%. This MDM SystemTM is a promising non-invasive method for diagnostic screening for ASD in children ages 2 to 11 years. These data also suggest approximately 90% of children with ASD have a distinct phenotype of ASD, which we propose naming ASD associated with Microbially-Derived Metabolites (ASD-MDM), defined by objective, quantitative laboratory measurements of these metabolites in urine.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Flynn CK, Carr K, Whiteley P, et al. Elevated microbially-derived metabolites in autism: a possible diagnostic screening test for a distinct ASD phenotype. Mol Psychiatry. 2026. PMID: 42192173. doi:10.1038/s41380-026-03620-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。